• FirefoxInstall the new Firefox »
  •  Dow Up 1.49% Nasdaq Up 1.15%

    Trevena, Inc. (TRVN)

    -NasdaqGS
    6.64 Down 0.33(4.73%) Mar 30, 4:00PM EDT
    Add to Portfolio
    Prev Close:6.97
    Open:7.03
    Bid:5.76 x 200
    Ask:7.45 x 1000
    1y Target Est:14.75
    Beta:N/A
    Earnings Date:May 7 - May 11 (Est.)
    Day's Range:6.55 - 7.45
    52wk Range:3.80 - 8.16
    Volume:230,006
    Avg Vol (3m):156,518
    Market Cap:260.56M
    P/E (ttm):N/A
    EPS (ttm):-2.02
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for TRVN

    Comparison

    Symbol% ChgMkt Cap
    TRVNDown 4.73%260.56M
    CYTKDown 0.84%274.59M
    NVSUp 0.91%243.00B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-1.76
    Quarterly EPS Est (Mar-15) :-0.33
    Mean Recommendation*:1.8
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Trevena, Inc., a clinical stage biopharmaceutical company, discovers, develops, and intends to commercialize therapeutics for G protein coupled receptors. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback